RxDoctor Payments DataLook up a doctor →

Steven Samuels, MD

Internal Medicine · Greenwood, INNPI 1205806387

Payments from drug & device makers

$72,283in general payments, 2019–2025

Across 1,693 payments — averaging $42.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$30K
  • GSK$13K
  • AstraZeneca$9K
  • AbbVie$3K
  • Amgen$2K
  • Johnson & Johnson$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer90$29,950
GSK195$13,352
AstraZeneca50$9,428
AbbVie(2 entities)228$3,017
Amgen(2 entities)224$2,316
Johnson & Johnson(2 entities)17$1,447
Pfizer95$1,208
Boehringer Ingelheim92$1,116
Novo Nordisk125$1,099
Harmony Biosciences LLC33$1,055
Lilly USA, LLC87$1,024
Jazz Pharmaceuticals Inc.24$689
Axsome Therapeutics, Inc.40$676
Novartis36$504
Takeda Pharmaceuticals U.S.A., Inc.48$468
Merck43$447
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)18$320
Avadel CNS Pharmaceuticals, LLC18$297
E.r. Squibb & Sons, L.L.C.21$264
UCB, Inc.11$213
Actelion Pharmaceuticals US, Inc.7$183
Amarin Pharma, Inc.12$180
Astellas Pharma US Inc9$161
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$150
Sanofi-aventis U.S. LLC9$136
Otsuka America Pharmaceutical, Inc.5$118
Sumitomo Pharma America, Inc.6$117
Grifols USA, LLC6$108
Paratek Pharmaceuticals, Inc.7$105
Radius Health, Inc.6$96
Biogen5$94
Dynavax Technologies Corporation5$94
Sunovion Pharmaceuticals Inc.7$84
Daiichi Sankyo Inc.5$80
Teva Pharmaceuticals USA, Inc.5$79
Seqirus USA Inc5$79
Pharming Healthcare, Inc.3$75
Xeris Pharmaceuticals, Inc.4$73
Nestle Healthcare Nutrition Inc.4$69
Exact Sciences4$68
Esperion Therapeutics, Inc.4$63
Regeneron Healthcare Solutions, Inc.3$59
Biohaven Pharmaceuticals, Inc.4$57
Kowa Pharmaceuticals America, Inc.5$57
Idorsia Pharmaceuticals US Inc3$50
Arbor Pharmaceuticals, Inc.2$50
United Therapeutics Corporation2$50
Antares Pharma, Inc.3$50
Shionogi Inc2$42
Corium, LLC2$41
Hologic Sales And Service, LLC3$41
Vanda Pharmaceuticals Inc.2$39
Masimo Corporation1$37
Sanofi2$35
Dexcom, Inc.2$34
Inspire Medical Systems, Inc.2$33
Eisai Inc.2$33
Avanir Pharmaceuticals, Inc.2$32
Abbott2$31
Mylan Specialty L.p.2$31

How this compares

$72,283 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$571,701
Medicare patients
1,481
Services billed
39,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Greenwood

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →